Eskornade in the treatment of diurnal incontinence in children.
This study examined 75 children with daytime wetting and particularly those with some form of bladder neck incompetence. There was a good response in 75% of cases to Eskornade (containing phenylpropanolamine, an alpha adrenergic agonist), but a lesser response in children with bladder instability. Large doses of this preparation have sometimes been necessary to produce urinary continence and side effects, although common, were usually minor and transient.